BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Olesen AE, Olofsen E, Olesen SS, Staahl C, Andresen T, Dahan A, Drewes AM. The absorption profile of pregabalin in chronic pancreatitis. Basic Clin Pharmacol Toxicol. 2012;111:385-390. [PMID: 22716224 DOI: 10.1111/j.1742-7843.2012.00914.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Drewes AM, Olesen AE, Farmer AD, Szigethy E, Rebours V, Olesen SS. Gastrointestinal pain. Nat Rev Dis Primers. 2020;6:1. [PMID: 31907359 DOI: 10.1038/s41572-019-0135-7] [Cited by in Crossref: 32] [Cited by in F6Publishing: 50] [Article Influence: 16.0] [Reference Citation Analysis]
2 Qin C, Wu M, Xu S, Wang X, Shi W, Dong Y, Yang L, He W, Han X, Yin L. Design and optimization of gastro-floating sustained-release tablet of pregabalin: In vitro and in vivo evaluation. Int J Pharm 2018;545:37-44. [PMID: 29649518 DOI: 10.1016/j.ijpharm.2018.04.011] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 5.5] [Reference Citation Analysis]
3 Singh VK, Drewes AM. Medical Management of Pain in Chronic Pancreatitis. Dig Dis Sci 2017;62:1721-8. [DOI: 10.1007/s10620-017-4605-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.2] [Reference Citation Analysis]
4 Hong T, Han S, Lee J, Jeon S, Yim DS. Comparison of oral absorption models for pregabalin: usefulness of transit compartment model. Drug Des Devel Ther 2016;10:3995-4003. [PMID: 27994441 DOI: 10.2147/DDDT.S123318] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
5 Siepsiak M, Szałek E, Karbownik A, Grabowski T, Mziray M, Adrych K, Grześkowiak E. Pharmacokinetics of paracetamol in patients with chronic pancreatitis. Pharmacol Rep 2016;68:733-6. [PMID: 27127912 DOI: 10.1016/j.pharep.2016.03.010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
6 Olesen AE, Brokjaer A, Fisher IW, Larsen IM. Pharmacological challenges in chronic pancreatitis. World J Gastroenterol 2013; 19(42): 7302-7307 [PMID: 24259961 DOI: 10.3748/wjg.v19.i42.7302] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
7 Olesen SS, Graversen C, Bouwense SA, van Goor H, Wilder-Smith OH, Drewes AM. Quantitative sensory testing predicts pregabalin efficacy in painful chronic pancreatitis. PLoS One. 2013;8:e57963. [PMID: 23469256 DOI: 10.1371/journal.pone.005796340] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Olesen SS, Graversen C, Bouwense SA, van Goor H, Wilder-Smith OH, Drewes AM. Quantitative sensory testing predicts pregabalin efficacy in painful chronic pancreatitis. PLoS One. 2013;8:e57963. [PMID: 23469256 DOI: 10.1371/journal.pone.0057963] [Cited by in Crossref: 76] [Cited by in F6Publishing: 79] [Article Influence: 8.4] [Reference Citation Analysis]